0.00
前日終値:
$0.2001
開ける:
$0
24時間の取引高:
0
Relative Volume:
0.00
時価総額:
$13.94M
収益:
-
当期純損益:
$-52.53M
株価収益率:
0.00
EPS:
-3.66
ネットキャッシュフロー:
$-39.93M
1週間 パフォーマンス:
-100.00%
1か月 パフォーマンス:
-100.00%
6か月 パフォーマンス:
-100.00%
1年 パフォーマンス:
-100.00%
Unity Biotechnology Inc Stock (UBX) Company Profile
名前
Unity Biotechnology Inc
セクター
電話
(650) 416-1192
住所
285 EAST GRAND AVENUE, SOUTH SAN FRANCISCO, CA
UBX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
UBX
Unity Biotechnology Inc
|
0.00 | 13.94M | 0 | -52.53M | -39.93M | -3.66 |
|
VRTX
Vertex Pharmaceuticals Inc
|
416.25 | 105.80B | 11.70B | 3.68B | 3.50B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
646.87 | 67.70B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
440.49 | 57.41B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
851.01 | 51.25B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
185.68 | 39.86B | 447.02M | -1.18B | -906.14M | -6.1812 |
Unity Biotechnology Inc Stock (UBX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-05-27 | ダウングレード | H.C. Wainwright | Buy → Neutral |
| 2025-05-16 | ダウングレード | Mizuho | Outperform → Neutral |
| 2024-08-22 | 開始されました | Rodman & Renshaw | Buy |
| 2023-11-16 | アップグレード | Wedbush | Neutral → Outperform |
| 2022-01-04 | アップグレード | ROTH Capital | Neutral → Buy |
| 2021-11-10 | アップグレード | Mizuho | Neutral → Buy |
| 2021-06-28 | アップグレード | Citigroup | Sell → Buy |
| 2021-06-07 | 開始されました | H.C. Wainwright | Buy |
| 2021-02-16 | ダウングレード | Citigroup | Neutral → Sell |
| 2020-08-18 | ダウングレード | Citigroup | Buy → Neutral |
| 2020-08-18 | ダウングレード | Mizuho | Buy → Neutral |
| 2020-08-18 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2020-08-17 | ダウングレード | ROTH Capital | Buy → Neutral |
| 2020-07-28 | 開始されました | ROTH Capital | Buy |
| 2019-12-12 | 開始されました | Cantor Fitzgerald | Overweight |
| 2019-03-07 | 開始されました | Cantor Fitzgerald | Overweight |
| 2018-09-07 | 開始されました | Mizuho | Buy |
| 2018-05-29 | 開始されました | Citigroup | Buy |
| 2018-05-29 | 開始されました | Goldman | Neutral |
| 2018-05-29 | 開始されました | Morgan Stanley | Overweight |
すべてを表示
Unity Biotechnology Inc (UBX) 最新ニュース
Why Unity Biotechnology Inc. stock is a value investor pickQuarterly Portfolio Review & Fast Gain Stock Trading Tips - fcp.pa.gov.br
Is Unity Biotechnology Inc. stock supported by strong fundamentals2025 Bull vs Bear & Daily Entry Point Trade Alerts - newser.com
Best data tools to analyze Unity Biotechnology Inc. stock2025 Earnings Surprises & Safe Entry Point Alerts - newser.com
Why Unity Biotechnology Inc. stock attracts global investorsTrade Ideas & Safe Swing Trade Setup Alerts - newser.com
Ranking Unity Biotechnology Inc. among high performing stocks via toolsMarket Sentiment Review & Safe Capital Preservation Plans - newser.com
Combining price and volume data for Unity Biotechnology Inc.2025 Technical Overview & Free Risk Controlled Daily Trade Plans - newser.com
Risk vs reward if holding onto Unity Biotechnology Inc.July 2025 Gainers & Safe Entry Trade Signal Reports - newser.com
Should you wait for a breakout in Unity Biotechnology Inc.Weekly Investment Recap & Risk Controlled Daily Trade Plans - newser.com
Will Unity Biotechnology Inc. stock go up soonForecast Cut & Daily Technical Forecast Reports - newser.com
Can Unity Biotechnology Inc. stock deliver strong Q4 earningsMarket Activity Summary & Weekly High Return Stock Forecasts - newser.com
Key resistance and support levels for Unity Biotechnology Inc.July 2025 Selloffs & AI Enhanced Trading Alerts - newser.com
Is Unity Biotechnology Inc. stock attractive after correction2025 Major Catalysts & Verified High Yield Trade Plans - newser.com
Working capital per share of Unity Biotechnology, Inc. – BER:9U90 - TradingView
Net current asset value per share of Unity Biotechnology, Inc. – GETTEX:9U90 - TradingView
Heatmap analysis for Unity Biotechnology Inc. and competitors2025 Buyback Activity & Consistent Profit Focused Trading Strategies - newser.com
Unity Biotechnology Inc (UBX) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):